A novel activating MAP2K1 in-frame deletion mediates acquired resistance to ROS1 TKIs in a patient with ROS1 fusion-positive NSCLC Meeting Abstract


Authors: Sato, H.; Schoenfeld, A.; Siau, E.; Suzawa, K.; Yue, C.; Offin, M.; Drilon, A.; Davare, M.; Riely, G.; Ladanyi, M.; Somwar, R.
Abstract Title: A novel activating MAP2K1 in-frame deletion mediates acquired resistance to ROS1 TKIs in a patient with ROS1 fusion-positive NSCLC
Meeting Title: 20th World Conference on Lung Cancer of the International Association for the Study of Lung Cancer (IASLC)
Keywords: non-small cell lung cancer; acquired resistance; ros1 fusion
Journal Title: Journal of Thoracic Oncology
Volume: 14
Issue: 10 Suppl.
Meeting Dates: 2019 Sept 7-10
Meeting Location: Barcelona, Spain
ISSN: 1556-0864
Publisher: Elsevier Inc.  
Date Published: 2019-09-01
Start Page: S556
End Page: S557
Language: English
ACCESSION: WOS:000492162203079
DOI: 10.1016/j.jtho.2019.08.1163
PROVIDER: wos
Notes: Meeting Abstract: P1.14-12 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Marc Ladanyi
    1326 Ladanyi
  2. Gregory J Riely
    599 Riely
  3. Romel Somwar
    110 Somwar
  4. Alexander Edward Drilon
    632 Drilon
  5. Michael David Offin
    170 Offin
  6. Evan Gelenn Dio Siau
    7 Siau
  7. Ken Suzawa
    11 Suzawa
  8. Hiroki Sato
    10 Sato